We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Mohawk Industries
MHK
$6.9B
| $404K | ﹤0.01% |
+2,104
| New | +$428K |
|
902
Conduent
CNDT
$230M
| $396K | ﹤0.01% |
52,785
| – | – |
|
903
Origin Bancorp
OBK
$1.66B
| $394K | ﹤0.01% |
9,287
-180
| -2% | -$7.81K |
|
904
FS Bancorp
FSBW
$324M
| $391K | ﹤0.01% |
10,982
-6,560
| -37% | -$227K |
|
905
RE/MAX Holdings
RMAX
$200M
| $391K | ﹤0.01% |
11,722
-8,661
| -42% | -$311K |
|
906
Mondelez International
MDLZ
$77.7B
| $383K | ﹤0.01% |
6,136
-200,931
| -97% | -$12.4M |
|
907
Plexus
PLXS
$6.81B
| $377K | ﹤0.01% |
+4,119
| New | +$386K |
|
908
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $374K | ﹤0.01% |
+10,539
| New | +$399K |
|
909
South Plains Financial
SPFI
$841M
| $370K | ﹤0.01% |
+15,997
| New | +$367K |
|
910
Genpact
G
$5.3B
| $366K | ﹤0.01% |
8,049
-32,207
| -80% | -$1.46M |
|
911
Bankwell Financial Group
BWFG
$496M
| $365K | ﹤0.01% |
+13,188
| New | +$369K |
|
912
ICF International
ICFI
$1.44B
| $362K | ﹤0.01% |
+4,121
| New | +$377K |
|
913
Hurco Companies Inc
HURC
$137M
| $352K | ﹤0.01% |
10,066
+2,852
| +40% | +$99.2K |
|
914
Key Tronic
KTCC
$40.3M
| $344K | ﹤0.01% |
+52,718
| New | +$376K |
|
915
Automatic Data Processing
ADP
$100B
| $338K | ﹤0.01% |
+1,702
| New | +$331K |
|
916
Shore Bancshares
SHBI
$790M
| $337K | ﹤0.01% |
20,114
-24,635
| -55% | -$417K |
|
917
AstroNova
ALOT
$223M
| $335K | ﹤0.01% |
24,056
| – | – |
|
918
Intuitive Surgical
ISRG
$121B
| $334K | ﹤0.01% |
1,089
-369
| -25% | -$104K |
|
919
Applied Optoelectronics
AAOI
$8.04B
| $330K | ﹤0.01% |
38,935
-93,245
| -71% | -$759K |
|
|
ARNC
920
DELISTED
Arconic Corporation
ARNC
| $330K | ﹤0.01% |
9,257
-141,750
| -94% | -$4.68M |
|
921
General Dynamics
GD
$105B
| $327K | ﹤0.01% |
+1,739
| New | +$328K |
|
|
TLIS
922
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $327K | ﹤0.01% |
+1,976
| New | +$336K |
|
923
Arcosa
ACA
$7.12B
| $325K | ﹤0.01% |
5,534
-45,448
| -89% | -$2.81M |
|
924
Global Indemnity Group
GBLI
$394M
| $321K | ﹤0.01% |
+11,893
| New | +$347K |
|
|
VBTX
925
DELISTED
Veritex Holdings
VBTX
| $318K | ﹤0.01% |
8,988
-17,826
| -66% | -$624K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.